Vita Therapeutics
PrivateLast Round
Series B
Oct 12, 2022
Total Funding Raised
$66M
Company Overview
Vita Therapeutics is a biotechnology company that develops engineered cellular therapies using induced pluripotent stem cell (iPSC) technology to treat neuromuscular diseases and cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vita Therapeutics Comparables
Compare Vita Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shoreline Biosciences | 85% | |
| IPS HEART | 77% | |
| Century Therapeutics | 76% | |
Vita Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 12, 2022 | ||||
| Series A | Jun 23, 2021 | ||||
| Seed | Jun 26, 2020 | ||||
| Grant | Jun 5, 2020 | ||||
| Seed | Jan 1, 2020 |
Key People
Founding team and executive leadership
Vita Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abell Foundation | Seed |
| TEDCO | Series B, Seed |
| Early Light Ventures | Series A |
| Johns Hopkins Technology Ventures | Series A |
| SCM Lifescience | Series A |
| Solve FSHD | Series B |
| Maryland Stem Cell Research Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2025
Launched a universal iPSC program for FSHD therapy.
- Oct 12, 2022
$31M round led by Cambrian Bio and Solve FSHD.
Vita Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vita Therapeutics's valuation, stock price, and market status.